Patient Derived Xenograft- PDX Models Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Patient Derived Xenograft- PDX Models Market size is expected to grow at an annual average CAGR of 15% during 2022-2028. Patient-derived xenografts (PDX) are cancer models in which tumor tissue or cells from a patient are transplanted into immunodeficient or humanized mice. The PDX model simulates human tumor biology allowing spontaneous cancer progression and provides the most translational research model for efficacy assessment. Patient-derived xenograft (PDX) mouse models involve the direct delivery of fresh human tumor samples to immunodeficient mice after surgical resection or other medical surgeries.

The following segmentation are covered in this report:

By Tumor Type

• Gastrointestinal Tumor Models
• Gynecological Tumor Models
• Respiratory Tumor Models
• Urological Tumor Models
• Hematological Tumor Models
• Other Tumor Models

 By End User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutions

By Application

• Preclinical Drug Development
• Biomarker Analysis
• Basic Cancer Research

By Type

• Mice Models
• Rat Models

Company Profile

• JSR Corporation (Japan)
• WuXi AppTec (China)
• Champions Oncology, Inc. (US)
• THE JACKSON LABORATORY (US)
• Charles River Laboratories (US)
• Oncodesign (France)
• Envigo (US)
• Pharmatest Services (Finland)
• Hera BioLabs (US)

Scope of the report

The research study analyses the Patient Derived Xenograft- PDX Models Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Patient Derived Xenograft- PDX Models Market Report

• What was the Patient Derived Xenograft- PDX Models Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Patient Derived Xenograft- PDX Models Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.